Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

November’s top stories: Patheon to buy API facility, UK NICE approved Celgene’s drug

Patheon agreed to acquire a new API manufacturing facility in the US, and UK NICE approved Celgene’s Imnovid drug for use in relapsed myeloma patients. wraps up the key headlines from November.

Go Top